PPD Announces First Quarter 2021 Earnings Conference Call
April 07 2021 - 8:00AM
Business Wire
PPD, Inc. (Nasdaq: PPD), a leading global contract research
organization, will host a conference call on Wednesday, April 28,
2021, at 8 a.m. (U.S. Eastern Time) to discuss its first quarter
2021 financial results. Investors and other interested parties may
listen to a live webcast of the conference call by logging on to
the investors section of PPD’s website at
https://investors.ppd.com. An archived copy of the webcast will be
available on the website after the call.
In addition, the conference call can be accessed live over the
phone by dialing +1 877 407 0784, or for international callers, +1
201 689 8560. A replay will be available after the call and can be
accessed by dialing +1 844 512 2921, or for international callers,
+1 412 317 6671. The passcode for the live conference call and the
replay is 13717929. The audio replay will be available until
Wednesday, May 12, 2021.
About PPD
PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and
lifecycle management services. Our customers include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With offices in 47 countries and more
than 26,000 professionals worldwide, PPD applies innovative
technologies, therapeutic expertise and a firm commitment to
quality to help customers bend the cost and time curve of drug
development and optimize value in delivering life-changing
therapies to improve health. For more information, visit
www.ppd.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210407005610/en/
PPD Investors: Tracy Krumme +1 910 558 4186
investors@ppd.com Media: media@ppd.com
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From May 2024 to Jun 2024
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Pharmaceutical Prod Dev (MM) (NASDAQ): 0 recent articles
More Pharmaceutical Prod Dev (MM) News Articles